Session Summary: Management of heart failure does not cease after durable MCS implantation and long-term untreated heart failure and persistent congestion can impact MCS morbidity and mortality. During this webinar, speakers will discuss the evaluation of hemodynamics and biomarkers in this patient population and how to optimize pump parameters to mitigate symptoms and optimize the patient-pump interaction. Additionally, speakers will discuss recent additions to the guideline directed medical therapy armamentarium for heart failure and how data from the heart failure literature can be extrapolated to durable MCS patients. Lastly, recovery, both full and partial will be discussed, and how this further impacts the patient-pump interaction.
Moderators:
Palak Shah, MD, MS, Inova Heart and Vascular Institute, Falls Church, VA, USA
Edward Horn, PharmD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
10:00 AM
Welcome and Introductions
Palak Shah, MD, Inova Heart and Vascular Institute, Falls Church, VA, USA
10:03 AM
Failure and Optimization: Using Biomarkers, Hemodynamics, and Echocardiography to Optimize the Pump
Manreet Kanwar, MD, Allegheny General Hospital, Pittsburgh, PA, USA
This speaker will discuss LVAD optimization techniques and monitoring parameters to ensure continued effective patient-pump interactions.
10:13 AM
Heart Failure Medical Therapy in 2021: How does this apply to my LVAD patient?
Douglas Jennings, PharmD, NY Presbyterian/Columbia University, New York, NY, USA
The speaker will describe how the current milieu of heart failure therapy applies to durable MCS patients.
10:23 AM
Partial Recovery Should be the Goal for All Patients after LVAD Implant
Evgenij Potapov, MD, PhD, German Heart Center, Berlin, Germany
The speaker will discuss how best to achieve partial recovery and why this is critical for long term LVAD patient survival.
10:33 AM
Live Q&A Discussion Led by Moderators
Including above speakers, plus:
- Thomas Schlöglhofer, MSc, Medical University of Vienna, Vienna, Austria
- Angela Lorts, MD, MBA, Cincinnati Children's Hospital, Cincinnati, OH, USA
10:58 AM
Closing Remarks
Edward Horn, PharmD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
10:59 AM
ISHLT Announcements
Greg Schultz, ISHLT CEO
